Alleviation of neuropathic pain with neuropeptide Y requires spinal Npy1r interneurons that coexpress Grp
Authors:
- Tyler S. NelsonTNTyler S. Nelson
- Heather N. AllenHAHeather N. Allen
- Paramita BasuParamita Basu
- Pranav PrasoonPPPranav Prasoon
- Cynthia M. ArokiarajCACynthia M. Arokiaraj
- Diogo F.S. SantosDSDiogo F.S. Santos
- Rebecca P. SealRSRebecca P. Seal
- Sarah E. RossSRSarah E. Ross
- Andrew J. ToddATAndrew J. Todd
- Bradley K. TaylorBTBradley K. Taylor
Open Access
- 22 November 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (22)
Abstract
Neuropeptide Y targets the Y1 receptor (Y1) in the spinal dorsal horn (DH) to produce endogenous and exogenous analgesia. DH interneurons that express Y1 (Y1-INs; encoded by Npy1r ) are necessary and sufficient for neuropathic hypersensitivity after peripheral nerve injury. However, as Y1-INs are heterogenous in composition in terms of morphology, neurophysiological characteristics, and gene expression, we hypothesized that a more precisely defined subpopulation mediates neuropathic hypersensitivity. Using fluorescence in situ hybridization, we found that Y1-INs segregate into 3 largely nonoverlapping subpopulations defined by the coexpression of Npy1r with gastrin-releasing peptide ( Grp / Npy1r ), neuropeptide FF ( Npff / Npy1r ), and cholecystokinin ( Cck / Npy1r ) in the superficial DH of mice, nonhuman primates, and humans. Next, we analyzed the functional significance of Grp / Npy1r , Npff / Npy1r , and Cck / Npy1r INs to neuropathic pain using a mouse model of peripheral nerve injury. We found that chemogenetic inhibition of Npff / Npy1r -INs did not change the behavioral signs of neuropathic pain. Further, inhibition of Y1-INs with an intrathecal Y1 agonist, [Leu 31 , Pro 34 ]-NPY, reduced neuropathic hypersensitivity in mice with conditional deletion of Npy1r from CCK-INs and NPFF-INs but not from GRP-INs. We conclude that Grp / Npy1r -INs are conserved in higher order mammalian species and represent a promising and precise pharmacotherapeutic target for the treatment of neuropathic pain.Keywords
Funding Information
- Office of Extramural Research (T32NS073548, F31NS117054, F99NS124190, R01DA37621, R01NS45954, R01NS62306, R01NS096705)
- Wellcome Trust (102645/Z/13/Z)
This publication has 91 references indexed in Scilit:
- A Transcription Factor Code Defines Nine Sensory Interneuron Subtypes in the Mechanosensory Area of the Spinal CordPLOS ONE, 2013
- A feed-forward spinal cord glycinergic neural circuit gates mechanical allodyniaJournal of Clinical Investigation, 2013
- Impaired Excitatory Drive to Spinal Gabaergic Neurons of Neuropathic MicePLOS ONE, 2013
- Fast Synaptic Inhibition in Spinal Sensory Processing and Pain ControlPhysiological Reviews, 2012
- Neuronal circuitry for pain processing in the dorsal hornNature Reviews Neuroscience, 2010
- Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPYNutrition, 2008
- Intrathecal neuropeptide Y reduces behavioral and molecular markers of inflammatory or neuropathic painPain, 2008
- Pirt, a Phosphoinositide-Binding Protein, Functions as a Regulatory Subunit of TRPV1Cell, 2008
- Glycine Inhibitory Dysfunction Turns Touch into Pain through PKCgamma InterneuronsPLOS ONE, 2007
- Neuropeptide tyrosine and painTrends in Pharmacological Sciences, 2007